Bone-Protecting Drug Combination Boosts Radiotherapy Against Lung Cancer Spread to Bone
A new translational study shows that adding RANKL inhibition to lutetium-177-labeled bisphosphonate radioligand therapy stabilizes the bone microenvironment and sharply ...
